DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Nifuroxazide

Generic Name: Nifuroxazide

Drug Type: Small Molecule

Chemical Formula: C_₁₂H_₉N_₃O_₅

CAS Number: 965-52-6

Unique Ingredient Identifier: PM5LI0P38J

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

Acute Diarrhea
Amebiasis
Colitis
Giardiasis
Liver Abscess, Amebic
Trichomonas Vaginitis

Clinical Trials

Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis

Phase 2

Recruiting

Posted: 2023/08/14

Sponsor:

Mostafa Bahaa

Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis

Phase 3

Recruiting

Posted: 2023/03/06

Sponsor:Cairo University

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

NIRABEN CAPSULE 200 mg

Manufacturer:Aprogen Pharmaceuticals, Inc.

Form:CAPSULE

Strength:200 mg

Online:Yes

Approved: 1999/06/03

Approval:SIN10966P

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy